PTPA and chronic obstructive pulmonary disease: Indeed, PP2A has been identified as a new player in chronic obstructive pulmonary disease (COPD) and asthma, and contributes to lung cancer initiation and progression by creating a tumor-promoting inflammatory microenvironment [158,159].